Molecular alterations in sporadic breast cancer

F Lerebours, R Lidereau - Critical reviews in oncology/hematology, 2002 - Elsevier
Breast cancer is a genetic disease. Like other human cancers, it is thought to occur as the
result of progressive accumulation of genetic aberrations. These aberrations result in a …

[HTML][HTML] Novel strategies on personalized medicine for breast cancer treatment: an update

CWH Chan, BMH Law, WKW So, KM Chow… - International journal of …, 2017 - mdpi.com
Breast cancer is the most common cancer type among women worldwide. With breast
cancer patients and survivors being reported to experience a repertoire of symptoms that are …

[HTML][HTML] Targeted therapy and mechanisms of drug resistance in breast cancer

B Kinnel, SK Singh, G Oprea-Ilies, R Singh - Cancers, 2023 - mdpi.com
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …

Somatic variation and cancer: therapies lost in the mix

AV Biankin, TJ Hudson - Human genetics, 2011 - Springer
Cancer arises as a consequence of mutations in genomes of cancer cells, which over time
allow them to proliferate and spread to distant sites. Large-scale sequencing of cancer …

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

A Hollestelle, JHA Nagel, M Smid, S Lam… - Breast cancer research …, 2010 - Springer
Breast cancer has for long been recognized as a highly diverse tumor group, but the
underlying genetic basis has been elusive. Here, we report an extensive molecular …

Subtype and pathway specific responses to anticancer compounds in breast cancer

LM Heiser, A Sadanandam, WL Kuo… - Proceedings of the …, 2012 - National Acad Sciences
Breast cancers are comprised of molecularly distinct subtypes that may respond differently to
pathway-targeted therapies now under development. Collections of breast cancer cell lines …

[HTML][HTML] Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets

N Zaman, L Li, ML Jaramillo, Z Sun, C Tibiche… - Cell reports, 2013 - cell.com
Individual cancer cells carry a bewildering number of distinct genomic alterations (eg, copy
number variations and mutations), making it a challenge to uncover genomic-driven …

Tumour heterogeneity of breast cancer: from morphology to personalised medicine

MA Aleskandarany, ME Vandenberghe, C Marchiò… - Pathobiology, 2018 - karger.com
Breast cancer (BC) displays striking clinical, morphological, and behavioural diversity within
a single tumour and between tumours. Currently, mounting evidence indicates that the …

Current status of prognostic profiling in breast cancer

L Pusztai - The Oncologist, 2008 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Assess
emerging data on the use of genetic groupings of breast cancer as predictive factors, and …

Through a glass darkly: advances in understanding breast cancer biology, 2000–2010

LA Carey - Clinical breast cancer, 2010 - Elsevier
Our understanding of breast cancer as a clinical and biologic entity has been gaining
granularity for several decades; in particular, the importance of hormone receptors and …